Skip to search formSkip to main contentSkip to account menu

Angiotensin-Converting Enzyme Inhibitors

Known as: Angiotensin Converting Enzyme Antagonists, Angiotensin I-Converting Enzyme Inhibitors, Inhibitors, Angiotensin-Converting Enzyme 
A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
Background—Angiotensin-converting enzyme 2 (ACE2) has emerged as a novel regulator of cardiac function and arterial pressure by… 
Highly Cited
2003
Highly Cited
2003
"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure… 
Highly Cited
2003
Highly Cited
2003
The National High Blood Pressure Education Program presents the complete Seventh Report of the Joint National Committee on… 
Highly Cited
2002
Highly Cited
2002
CONTEXT Antihypertensive therapy is well established to reduce hypertension-related morbidity and mortality, but the optimal… 
Highly Cited
2000
Highly Cited
2000
BACKGROUND Angiotensin-converting-enzyme inhibitors improve the outcome among patients with left ventricular dysfunction, whether… 
Highly Cited
2000
Highly Cited
2000
A novel human zinc metalloprotease that has considerable homology to human angiotensin-converting enzyme (ACE) (40% identity and… 
Review
1998
Review
1998
ACE inhibitors have achieved widespread usage in the treatment of cardiovascular and renal disease. ACE inhibitors alter the… 
Highly Cited
1996
Highly Cited
1996
Background Drugs that inhibit angiotensin-converting enzyme slow the progression of renal insufficiency in patients with diabetic… 
Review
1995
Review
1995
Objective. —To evaluate the effect of angiotensin-converting enzyme (ACE) inhibitors on mortality and morbidity in patients with…